Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy Subjects
Clinical trial NCT03828084 · COMPLETED
Trial details
- NCT number
- NCT03828084
- Sponsor
- EpiDestiny, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2019-05-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.